Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.15 |
---|---|
High | 2.23 |
Low | 2.14 |
Bid | 2.14 |
Offer | 2.22 |
Previous close | 2.12 |
Average volume | 12.90k |
---|---|
Shares outstanding | 6.99m |
Free float | 5.44m |
P/E (TTM) | -- |
Market cap | 14.83m USD |
EPS (TTM) | -0.4357 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:11 GMT.
More ▼
- Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
- Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
- Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
More ▼